PT  - JOURNAL ARTICLE
AU  - Gordon, Debra
ED  - Bozaite-Gluosniene, Rasa
TI  - Reduced CV Risk with Use of MTX and TNF-α Inhibitors in Patients with RA
DP  - 2011  01
TA  - MD Conference Express
PG  - 13--14
VI  - 11
IP  - 13
4099  - http://mdc.sagepub.com/content/11/13/13.2.short
4100  - http://mdc.sagepub.com/content/11/13/13.2.full
AB  - Patients with rheumatoid arthritis who did not have preexisting coronary artery disease and used methotrexate (MTX) for at least 24 months or a tumor necrosis factor (TNF) antagonist for at least 40 months were significantly less likely to develop cardiovascular disease than those who did not use MTX or anti -TNF therapy.